Search results
Campaign fuels efforts to find better treatments for blood cancers in children
NBC Dallas Fort Worth· 11 hours agoLeukemia and Lymphoma Society's (LLS) Dare to Dream project hopes to raise money for research of...
Cellular Fountain of Youth: New T-Cell Discovery Rewrites the Rules of Aging
SciTechDaily· 3 hours agoResearchers at St. Jude Children’s Research Hospital and the University of Minnesota have discovered...
Health inequities: How socioeconomic factors affect outcomes for pediatric cancer patients
Medical Xpress· 15 hours agoIt's important for everyone–health care providers, donors, researchers, educators, advocates, and...
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
The Yuma Sun· 5 days ago- Oral presentation highlighting final five-year efficacy data from the registrational Phase 2 trial of REZLIDHIA® (olutasidenib) in heavily pretreated patients with R/R mIDH1 AML, including those receiving prior venetoclax
Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including...
FOX 23 News Albany· 1 day agoIn the results, olverembatinib showed excellent durable clinical benefits and favorable long-term tolerability in patients who had been treated with multiple TKIs (including those...
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials...
Morningstar· 2 days agoFN Media Group News Commentary - According to a report from Mordor Intelligence the Acute Myeloid Leukemia Market size is estimated at USD 1.83 billion in 2024, and is expected ...
"I'm brave and I'm strong": 5-year-old overcomes years of painful cancer treatments
CBS News· 14 hours ago"I'm brave and I'm strong and I can do all things," Arianna says. In July 2020, at 21 months old and...
EHA 2024: Novartis Scemblix takes on all TKIs in head-to-head CML trial
Clinical Trials Arena via Yahoo Finance· 2 days agoWhile the differences in side effect rates...associated side effects less suitable. Given the...
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
Zacks via Yahoo Finance· 5 days agoShattuck (STTK) will now focus on higher-risk myelodysplastic syndromes and TP53 mutant acute...
Treatment of Blood Cancers
Digital Journal· 17 hours ago(NYSE American: ATNM). Actinium is a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies. Approximately every 3 minutes, one person in the US ...